Press release – No. 1 / 2023 Zealand Pharma to Host Conference Call on March 2, 2023 at 2 pm…
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – February 24, 2023 –…
MARKHAM, Ontario, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced…
CLINUVEL Financial Performance CLINUVEL Group financial performance for the half year ended 30 December, since first commercial sales.MELBOURNE, Australia, Feb.…
Aventura, Feb. 23, 2023 (GLOBE NEWSWIRE) -- On February 9, 2023, Modern Vascular facilities received letters from the CMS program…
CLEVELAND, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global…
Combined company will be focused on advancing Enliven’s clinical-stage pipeline of precision oncology programs Shares to trade on Nasdaq under…
Primary Endpoints Demonstrate CTx-1301 Can be Taken With or Without Food CTx-1301 is Designed as a True, Entire Active-Day Treatment…
– Initiated enrollment in Phase 1B clinical trial of SL-172154 in combination with mirvetuximab soravtansine in platinum-resistant ovarian cancer –…
— Company expects to announce data for Factor VIII expression in non-human primates in 2023 — Strong cash balance of…